Product Name
CAVIN1, Polyclonal Antibody
Full Product Name
CAVIN1 Antibody - C-terminal region
Product Gene Name
anti-CAVIN1 antibody
[Similar Products]
Product Synonym Gene Name
CGL4; PTRF; CAVIN; FKSG13; cavin-1[Similar Products]
Antibody/Peptide Pairs
CAVIN1 peptide (MBS3244039) is used for blocking the activity of CAVIN1 antibody (MBS3219147)
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Immunogen Sequence
Synthetic peptide located within the following region: EESRAERIKR SGLRRVDDFK KAFSKEKMEK TKVRTRENLE KTRLKTKENL
3D Structure
ModBase 3D Structure for Q6NZI2
Purity/Purification
Affinity Purified
Form/Format
Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
Immunogen
The immunogen is a synthetic peptide directed towards the C-terminal region of Human PTRF
Preparation and Storage
For short term use, store at 2-8 degree C up to 1 week. For long term storage, store at -20 degree C in small aliquots to prevent freeze-thaw cycles.
Other Notes
Small volumes of anti-CAVIN1 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-CAVIN1 antibody
This is a rabbit polyclonal antibody against PTRF. It was validated on Western Blot
Target Description: This gene encodes a protein that enables the dissociation of paused ternary polymerase I transcription complexes from the 3' end of pre-rRNA transcripts. This protein regulates rRNA transcription by promoting the dissociation of transcription complexes and the reinitiation of polymerase I on nascent rRNA transcripts. This protein also localizes to caveolae at the plasma membrane and is thought to play a critical role in the formation of caveolae and the stabilization of caveolins. This protein translocates from caveolae to the cytoplasm after insulin stimulation. Caveolae contain truncated forms of this protein and may be the site of phosphorylation-dependent proteolysis. This protein is also thought to modify lipid metabolism and insulin-regulated gene expression. Mutations in this gene result in a disorder characterized by generalized lipodystrophy and muscular dystrophy.
Product Categories/Family for anti-CAVIN1 antibody
Polyclonal; Transcription Factor; Membrane Protein; Disease Related;
Applications Tested/Suitable for anti-CAVIN1 antibody
Western Blot (WB)
Western Blot (WB) of anti-CAVIN1 antibody
Host: Rabbit
Target Name: PTRF
Sample Type: MCF7 Whole Cell lysates
Antibody Dilution: 1.0ug/ml

NCBI/Uniprot data below describe general gene information for CAVIN1. It may not necessarily be applicable to this product.
NCBI Accession #
NP_036364
[Other Products]
NCBI GenBank Nucleotide #
NM_012232.6
[Other Products]
UniProt Primary Accession #
Q6NZI2
[Other Products]
UniProt Related Accession #
Q6NZI2[Other Products]
NCBI Official Full Name
caveolae-associated protein 1
NCBI Official Synonym Full Names
caveolae associated protein 1
NCBI Official Symbol
CAVIN1??[Similar Products]
NCBI Official Synonym Symbols
CGL4; PTRF; CAVIN; FKSG13; cavin-1
??[Similar Products]
NCBI Protein Information
caveolae-associated protein 1
UniProt Protein Name
Polymerase I and transcript release factor
UniProt Synonym Protein Names
Cavin-1
UniProt Gene Name
PTRF??[Similar Products]
UniProt Entry Name
PTRF_HUMAN
NCBI Summary for CAVIN1
This gene encodes a protein that enables the dissociation of paused ternary polymerase I transcription complexes from the 3' end of pre-rRNA transcripts. This protein regulates rRNA transcription by promoting the dissociation of transcription complexes and the reinitiation of polymerase I on nascent rRNA transcripts. This protein also localizes to caveolae at the plasma membrane and is thought to play a critical role in the formation of caveolae and the stabilization of caveolins. This protein translocates from caveolae to the cytoplasm after insulin stimulation. Caveolae contain truncated forms of this protein and may be the site of phosphorylation-dependent proteolysis. This protein is also thought to modify lipid metabolism and insulin-regulated gene expression. Mutations in this gene result in a disorder characterized by generalized lipodystrophy and muscular dystrophy. [provided by RefSeq, Nov 2009]
UniProt Comments for CAVIN1
PTRF: Plays an important role in caveolae formation and organization. Required for the sequestration of mobile caveolin into immobile caveolae. Termination of transcription by RNA polymerase I involves pausing of transcription by TTF1, and the dissociation of the transcription complex, releasing pre-rRNA and RNA polymerase I from the template. PTRF is required for dissociation of the ternary transcription complex. Defects in PTRF are the cause of congenital generalized lipodystrophy type 4 (CGL4). It is a disorder characterized by the association of congenital generalized lipodystrophy with muscular dystrophy and cardiac anomalies. Congenital generalized lipodystrophy is characterized by a near complete absence of adipose tissue, extreme insulin resistance, hypertriglyceridemia, hepatic steatosis and early onset of diabetes. Belongs to the PTRF/SDPR family. 3 isoforms of the human protein are produced by alternative splicing.
Protein type: Transcription initiation complex
Chromosomal Location of Human Ortholog: 17q21.2
Cellular Component: nucleoplasm; protein complex; mitochondrion; intracellular membrane-bound organelle; endoplasmic reticulum; cytoplasm; plasma membrane; caveola; cytosol; nucleus
Molecular Function: protein binding; rRNA primary transcript binding
Biological Process: regulation of transcription, DNA-dependent; transcription from RNA polymerase I promoter; gene expression; termination of RNA polymerase I transcription; transcription initiation from RNA polymerase I promoter
Disease: Lipodystrophy, Congenital Generalized, Type 4
Research Articles on CAVIN1
1. Overexpressing PTRF induced the malignancy of nearby cells in vivo, suggesting that PTRF alters the microenvironment through intercellular communication via exosomes in glioblastoma.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.